Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo) 2025

Award

Value

£105,600

Classifications

  • Pharmaceutical products

Tags

  • award

Submission Deadline

7 months ago

Published

6 months ago

Description

Provision of radiopharmaceuticals for treatment of prostate cancer - Xofigo.

Additional information: 
Below threshold Direct Award. Bayer PLC are the only supplier of Xofigo and no alternative products are on the market.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete